• Fulkerson Lab Research

    Our research focuses on the biology of the eosinophil-lineage committed progenitor (EoP). We aim to identify novel therapeutic targets to regulate eosinophil production for the treatment of patients with inflammatory disorders by investigating transcriptional regulation of EoP generation and identifying and characterizing pathways important for EoP survival, proliferation and differentiation into mature eosinophils.

    We have developed a number of innovative methods to study the regulation of eosinophil development including liquid culture systems in which we can follow differentiation of both murine and human eosinophil-lineage committed progenitors (EoPs) into mature effector eosinophils.

    The pathways that we identify in our culture systems are tested in models of hypereosinophilia, infection and allergic inflammation to further characterize the clinical and therapeutic potential of candidate targets.

    Fulkerson Lab

    Why study eosinophil development?

    Eosinophil-associated disorders, including eosinophilic gastrointestinal disorders and asthma, are widely prevalent in developed and developing countries.

    Current therapies can be effective, but resistance and toxic side effects often develop. New therapeutic agents are needed to treat patients with eosinophilic disorders.

  • Eosinophil Progenitor Differentiation

    Eosinophil Progenitor Differentiation
    Mature eosinophils derived from ex vivo bone marrow cultures.Read More
  • Eosinophil-Lineage Commitment

    Eosinophil-lineage Commitment

    Stem cell differentiation colony containing myeloid progenitors.

    Read More
  • Fulkerson Lab

    Fulkerson Lab Strategy Session

  • Targeting Eosinophil Progenitors in Asthma

    Learn more about how eosinophil progenitors contribute to asthma. 

    Read More
  • Contact Us

    Patricia C. Fulkerson, MD, PhD
    For more information about our research and training opportunities, contact Patricia C. Fulkerson, MD, PhD.Contact Us